[New therapeutic aspects in age-related macular degeneration]

MeSH terms

• Aged
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Humanized
• Aptamers, Nucleotide / administration & dosage
• Aptamers, Nucleotide / therapeutic use
• Clinical Trials, Phase III as Topic
• Disease Progression
• Forecasting
• Humans
• Macular Degeneration / diagnosis
• Macular Degeneration / drug therapy
• Macular Degeneration / etiology
• Macular Degeneration / therapy*
• Middle Aged
• Multicenter Studies as Topic
• Photochemotherapy
• Photosensitizing Agents / therapeutic use
• Porphyrins / administration & dosage
• Porphyrins / therapeutic use
• Randomized Controlled Trials as Topic
• Ranibizumab
• Risk Factors
• Smoking / adverse effects
• Smoking Cessation
• Vascular Endothelial Growth Factor A / antagonists & inhibitors
• Verteporfin
• Visual Acuity